60 Degrees Pharmaceuticals Inc

SXTPW



詳細チャートを表示

0.065USD

+0.002+3.50%

終値（ET）15分遅れの株価

0.00時価総額

--直近12ヶ月PER



60 Degrees Pharmaceuticals Inc

0.065

+0.002+3.50%

概要企業名金融分析

概要

企業名

金融

分析

Intraday

30m

本日

+3.50%

5日間

+21.04%

1ヶ月

+75.20%

6ヶ月

0.00%

年初来

+3.50%

1年間

+150.97%

詳細チャートを表示

TradingKey 株式スコア

データが不十分なため、株式スコアは利用できません。

60 Degrees Pharmaceuticals Inc ニュース

最新情報をお待ちください...

財務指標

EPS

会社から関連データがまだ開示されていません。

総売上高

会社から関連データがまだ開示されていません。

60 Degrees Pharmaceuticals Incの企業情報

60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. It is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The Company's pipeline under development covers development programs for vector-borne, fungal, and viral disease utilizing three of the Company’s products: new products that contain the ARAKODA regimen of Tafenoquine; new products that contain Tafenoquine, and Celgosivir. Its lead product, ARAKODA is an antimalarial indicated for the prophylaxis of malaria in patients aged 18 years of age and older. It is also conducting due diligence activities in relation to potential in-licensing of a product relevant to Lyme disease and an antimalarial combination partner for Tafenoquine for P. vivax malaria.

企業コードSXTPW

企業名60 Degrees Pharmaceuticals Inc

最高経営責任者「CEO」Dr. Ll S. Dow, Ph.D.

ウェブサイトhttps://60degreespharma.com/